300267.SZ
Price:
$3.12
Market Cap:
$6.44B
Hunan Er-Kang Pharmaceutical Co., Ltd manufactures and sells APIs, finished drug products, and pharmaceutical excipients in China and internationally. Its APIs include glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's finished drugs primarily comprise sulbenicillin sodium for injection and compound liquorice tablets. Its conventional pharmaceutical excipients include pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose; and new pharmaceutical excipients comprise hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrat...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-09-27
Stock Exchange
SHZ
Ticker
300267.SZ
According to Hunan Er-Kang Pharmaceutical Co., Ltd’s latest financial reports and current stock price. The company's current PE Ratio is -18.35. This represents a change of -123.05% compared to the average of 79.60 of the last 4 quarters.
The mean historical PE Ratio of Hunan Er-Kang Pharmaceutical Co., Ltd over the last ten years is 32.98. The current -18.35 PE Ratio has changed -5663.50% with respect to the historical average. Over the past ten years (40 quarters), 300267.SZ's PE Ratio was at its highest in in the March 2024 quarter at 483.40. The PE Ratio was at its lowest in in the December 2019 quarter at -497.66.
Average
32.98
Median
29.97
Minimum
-34.00
Maximum
159.37
Discovering the peaks and valleys of Hunan Er-Kang Pharmaceutical Co., Ltd PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 88.00%
Maximum Annual PE Ratio = 159.37
Minimum Annual Increase = -1389.73%
Minimum Annual PE Ratio = -34.00
Year | PE Ratio | Change |
---|---|---|
2024 | -15.36 | -54.83% |
2023 | -34.00 | -121.34% |
2022 | 159.37 | -1389.73% |
2021 | -12.36 | -127.37% |
2020 | 45.15 | -31.47% |
2019 | 65.89 | 88.00% |
2018 | 35.05 | 33.90% |
2017 | 26.17 | -22.49% |
2016 | 33.77 | 29.19% |
2015 | 26.14 | -57.62% |
The current PE Ratio of Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
36.67
5-year avg
28.56
10-year avg
32.98
Hunan Er-Kang Pharmaceutical Co., Ltd’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hunan Er-Kang Pharmaceutical Co., Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hunan Er-Kang Pharmaceutical Co., Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hunan Er-Kang Pharmaceutical Co., Ltd's PE Ratio?
How is the PE Ratio calculated for Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)?
What is the highest PE Ratio for Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)?
What is the 3-year average PE Ratio for Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)?
What is the 5-year average PE Ratio for Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ)?
How does the current PE Ratio for Hunan Er-Kang Pharmaceutical Co., Ltd (300267.SZ) compare to its historical average?